The cover story of the September issue of Arizona Attorney was written by Professor Gary Marchant, executive director of the Center for the Study of Law, Science, & Technology, and Lincoln Professor of Emerging Technologies, Law & Ethics.
In an article headlined, "Personalized Medicine and the Law," Marchant defined the antithesis of the "one size fits all" approach to medicine as "the right treatment at the right dose at the right time for the right patient with the right disease." In personalized medicine, diagnoses and treatments are tailored to the genetic and molecular profiles of specific patients and their diseases, he wrote.
With the advent of personalized medicine, however, come challenges of liability, regulation, business and ethics, which Marchant also discusses in detail in his article. To meet the growing need for genetically sophisticated lawyers, the College recently launched the nation's first LL.M. in Biotechnology and Genomics.
"Just as the practice of medicine will change dramatically over the next decade as personalized medicine becomes the new dominant model for health-care delivery, so too will the practice of law need to change dramatically," he wrote.